Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02643316 · ClinicalTrials.gov registry record · NA

Morning-Only 4 L PEG vs Split Dose Prep for Afternoon Colonoscopies, Endoscopist-Blinded Prospective Study

A NA study of Colonoscopy, sponsored by The Cleveland Clinic.

Completed
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT02643316 is a NA study of Colonoscopy that has completed, run by The Cleveland Clinic. The registered enrollment target is 200 participants, below the 492-participant average among 20 other Colonoscopy trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02643316, a NA study of Colonoscopy, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

Comparison of quality of preparation of colonoscopy in patients taking same day 4L preparation vs. 4 L split dose preparation in patients scheduled for an afternoon colonoscopy procedure.

Conditions Studied

Interventions

  • DRUG Same day 4 L preparation (Polyethylene Glycol)
  • DRUG Split dose 4 L preparation (Polyethylene Glycol)

Study Locations (1)

Florida

  • Cleveland Clinic Florida - Weston

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2015-12
Est. Completion 2019-08
Phase NA

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT02643316

The ClinicalTrials.gov registry entry for NCT02643316 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 492-participant average among 20 other Colonoscopy trials with a reported enrollment target (59% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Colonoscopy appearing as the primary indexed condition, and to 2 interventions - of which Same day 4 L preparation (Polyethylene Glycol) is the first listed.

NCT02643316 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT02643316 about?

NCT02643316 is a clinical study titled "Morning-Only 4 L PEG vs Split Dose Prep for Afternoon Colonoscopies, Endoscopist-Blinded Prospective Study". Comparison of quality of preparation of colonoscopy in patients taking same day 4L preparation vs. 4 L split dose preparation in patients scheduled for an afternoon colonoscopy procedure.

What is the current status of trial NCT02643316?

This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2015-12. Estimated completion is 2019-08.

What conditions does trial NCT02643316 study?

This clinical trial studies the following conditions: Colonoscopy.

What interventions are being tested in trial NCT02643316?

The interventions under investigation include: Same day 4 L preparation (Polyethylene Glycol) (DRUG), Split dose 4 L preparation (Polyethylene Glycol) (DRUG).

Who is sponsoring clinical trial NCT02643316?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02643316 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colonoscopy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.